Annual Working Capital
$14.72 B
-$1.34 B-8.34%
December 31, 2024
Summary
- As of February 20, 2025, REGN annual working capital is $14.72 billion, with the most recent change of -$1.34 billion (-8.34%) on December 31, 2024.
- During the last 3 years, REGN annual working capital has risen by +$4.63 billion (+45.96%).
- REGN annual working capital is now -8.34% below its all-time high of $16.06 billion, reached on December 31, 2023.
Performance
REGN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$14.72 B
-$956.00 M-6.10%
December 31, 2024
Summary
- As of February 20, 2025, REGN quarterly working capital is $14.72 billion, with the most recent change of -$956.00 million (-6.10%) on December 31, 2024.
- Over the past year, REGN quarterly working capital has dropped by -$1.34 billion (-8.34%).
- REGN quarterly working capital is now -8.34% below its all-time high of $16.06 billion, reached on December 31, 2023.
Performance
REGN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
REGN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.3% | -8.3% |
| 3 y3 years | +46.0% | -8.3% |
| 5 y5 years | +163.2% | -8.3% |
REGN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.3% | +46.0% | -8.3% | +46.0% |
| 5 y | 5-year | -8.3% | +163.2% | -8.3% | +253.9% |
| alltime | all time | -8.3% | >+9999.0% | -8.3% | >+9999.0% |
Regeneron Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $14.72 B(-8.3%) | $14.72 B(-6.1%) |
| Sep 2024 | - | $15.67 B(+0.6%) |
| Jun 2024 | - | $15.57 B(+1.8%) |
| Mar 2024 | - | $15.29 B(-4.8%) |
| Dec 2023 | $16.06 B(+26.0%) | $16.06 B(+6.8%) |
| Sep 2023 | - | $15.04 B(+8.8%) |
| Jun 2023 | - | $13.82 B(+0.1%) |
| Mar 2023 | - | $13.81 B(+8.4%) |
| Dec 2022 | $12.74 B(+26.4%) | $12.74 B(+1.5%) |
| Sep 2022 | - | $12.55 B(+0.4%) |
| Jun 2022 | - | $12.50 B(+10.6%) |
| Mar 2022 | - | $11.30 B(+12.1%) |
| Dec 2021 | $10.08 B(+42.4%) | $10.08 B(+0.2%) |
| Sep 2021 | - | $10.06 B(+4.7%) |
| Jun 2021 | - | $9.61 B(+40.5%) |
| Mar 2021 | - | $6.84 B(-3.5%) |
| Dec 2020 | $7.08 B(+26.6%) | $7.08 B(+4.8%) |
| Sep 2020 | - | $6.76 B(+62.6%) |
| Jun 2020 | - | $4.16 B(-36.9%) |
| Mar 2020 | - | $6.59 B(+17.8%) |
| Dec 2019 | $5.59 B(+11.7%) | $5.59 B(+4.7%) |
| Sep 2019 | - | $5.34 B(+8.2%) |
| Jun 2019 | - | $4.94 B(-8.8%) |
| Mar 2019 | - | $5.42 B(+8.2%) |
| Dec 2018 | $5.00 B(+56.4%) | $5.00 B(+16.3%) |
| Sep 2018 | - | $4.30 B(+23.5%) |
| Jun 2018 | - | $3.48 B(+6.2%) |
| Mar 2018 | - | $3.28 B(+2.5%) |
| Dec 2017 | $3.20 B(+65.0%) | $3.20 B(+6.8%) |
| Sep 2017 | - | $3.00 B(+5.9%) |
| Jun 2017 | - | $2.83 B(+19.9%) |
| Mar 2017 | - | $2.36 B(+21.8%) |
| Dec 2016 | $1.94 B(-7.9%) | $1.94 B(-23.7%) |
| Sep 2016 | - | $2.54 B(+12.5%) |
| Jun 2016 | - | $2.26 B(+2.0%) |
| Mar 2016 | - | $2.21 B(+5.2%) |
| Dec 2015 | $2.10 B(+47.1%) | $2.10 B(+8.4%) |
| Sep 2015 | - | $1.94 B(+15.4%) |
| Jun 2015 | - | $1.68 B(-5.2%) |
| Mar 2015 | - | $1.77 B(+24.1%) |
| Dec 2014 | $1.43 B(-4.5%) | $1.43 B(-20.1%) |
| Sep 2014 | - | $1.79 B(+14.2%) |
| Jun 2014 | - | $1.57 B(+0.1%) |
| Mar 2014 | - | $1.57 B(+4.5%) |
| Dec 2013 | $1.50 B(+43.7%) | $1.50 B(+9.7%) |
| Sep 2013 | - | $1.37 B(+0.6%) |
| Jun 2013 | - | $1.36 B(+22.3%) |
| Mar 2013 | - | $1.11 B(+6.5%) |
| Dec 2012 | $1.04 B(+101.4%) | $1.04 B(+35.4%) |
| Sep 2012 | - | $770.03 M(+31.4%) |
| Jun 2012 | - | $585.97 M(+9.2%) |
| Mar 2012 | - | $536.53 M(+3.7%) |
| Dec 2011 | $517.51 M(+108.2%) | $517.51 M(+150.4%) |
| Sep 2011 | - | $206.64 M(-25.5%) |
| Jun 2011 | - | $277.40 M(+30.1%) |
| Mar 2011 | - | $213.25 M(-14.2%) |
| Dec 2010 | $248.57 M(-25.1%) | $248.57 M(-43.7%) |
| Sep 2010 | - | $441.89 M(+48.2%) |
| Jun 2010 | - | $298.18 M(+2.3%) |
| Mar 2010 | - | $291.35 M(-12.2%) |
| Dec 2009 | $331.93 M(-24.2%) | $331.93 M(-4.5%) |
| Sep 2009 | - | $347.43 M(+0.8%) |
| Jun 2009 | - | $344.61 M(-9.5%) |
| Mar 2009 | - | $380.68 M(-13.0%) |
| Dec 2008 | $437.77 M(-14.9%) | $437.77 M(-12.1%) |
| Sep 2008 | - | $497.77 M(-4.0%) |
| Jun 2008 | - | $518.48 M(+3.4%) |
| Mar 2008 | - | $501.55 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $514.16 M(+21.0%) | $514.16 M(+58.0%) |
| Sep 2007 | - | $325.33 M(-17.0%) |
| Jun 2007 | - | $392.15 M(-3.3%) |
| Mar 2007 | - | $405.56 M(-4.6%) |
| Dec 2006 | $424.97 M(+41.2%) | $424.97 M(+76.3%) |
| Sep 2006 | - | $241.05 M(-7.1%) |
| Jun 2006 | - | $259.55 M(-9.2%) |
| Mar 2006 | - | $285.98 M(-5.0%) |
| Dec 2005 | $301.04 M(-2.8%) | $301.04 M(+3.3%) |
| Sep 2005 | - | $291.44 M(-11.5%) |
| Jun 2005 | - | $329.36 M(-3.1%) |
| Mar 2005 | - | $339.92 M(+9.7%) |
| Dec 2004 | $309.82 M(+25.3%) | $309.82 M(+12.5%) |
| Sep 2004 | - | $275.34 M(-20.4%) |
| Jun 2004 | - | $345.96 M(-2.8%) |
| Mar 2004 | - | $355.95 M(+43.9%) |
| Dec 2003 | $247.28 M(+4.4%) | $247.28 M(-29.3%) |
| Sep 2003 | - | $349.64 M(+42.1%) |
| Jun 2003 | - | $246.09 M(-9.0%) |
| Mar 2003 | - | $270.37 M(+14.2%) |
| Dec 2002 | $236.83 M(-36.4%) | $236.83 M(-15.8%) |
| Sep 2002 | - | $281.17 M(-2.4%) |
| Jun 2002 | - | $288.23 M(-8.3%) |
| Mar 2002 | - | $314.17 M(-15.6%) |
| Dec 2001 | $372.16 M(+209.2%) | $372.16 M(+56.2%) |
| Sep 2001 | - | $238.31 M(-0.6%) |
| Jun 2001 | - | $239.86 M(-12.1%) |
| Mar 2001 | - | $272.78 M(+126.6%) |
| Dec 2000 | $120.36 M(+101.6%) | $120.36 M(-3.1%) |
| Sep 2000 | - | $124.26 M(-0.1%) |
| Jun 2000 | - | $124.44 M(+103.9%) |
| Mar 2000 | - | $61.03 M(+2.2%) |
| Dec 1999 | $59.70 M(-28.5%) | $59.70 M(-8.6%) |
| Sep 1999 | - | $65.30 M(-3.3%) |
| Jun 1999 | - | $67.50 M(+1.8%) |
| Mar 1999 | - | $66.30 M(-20.6%) |
| Dec 1998 | $83.50 M(-6.1%) | $83.50 M(+4.9%) |
| Sep 1998 | - | $79.60 M(-0.4%) |
| Jun 1998 | - | $79.90 M(-4.2%) |
| Mar 1998 | - | $83.40 M(-6.2%) |
| Dec 1997 | $88.90 M(+21.8%) | $88.90 M(-5.7%) |
| Sep 1997 | - | $94.30 M(-5.5%) |
| Jun 1997 | - | $99.80 M(+60.5%) |
| Mar 1997 | - | $62.20 M(-14.8%) |
| Dec 1996 | $73.00 M(+101.1%) | $73.00 M(+13.2%) |
| Sep 1996 | - | $64.50 M(-10.5%) |
| Jun 1996 | - | $72.10 M(+157.5%) |
| Mar 1996 | - | $28.00 M(-22.9%) |
| Dec 1995 | $36.30 M(+6.5%) | $36.30 M(+120.0%) |
| Sep 1995 | - | $16.50 M(-29.2%) |
| Jun 1995 | - | $23.30 M(-3.7%) |
| Mar 1995 | - | $24.20 M(-29.0%) |
| Dec 1994 | $34.10 M(-56.7%) | $34.10 M(+11.8%) |
| Sep 1994 | - | $30.50 M(-9.2%) |
| Jun 1994 | - | $33.60 M(0.0%) |
| Mar 1994 | - | $33.60 M(-57.3%) |
| Dec 1993 | $78.70 M(-1.7%) | $78.70 M(-21.5%) |
| Sep 1993 | - | $100.20 M(+66.2%) |
| Jun 1993 | - | $60.30 M(-14.6%) |
| Mar 1993 | - | $70.60 M(-11.9%) |
| Dec 1992 | $80.10 M(-22.5%) | $80.10 M(-7.5%) |
| Sep 1992 | - | $86.60 M(-7.1%) |
| Jun 1992 | - | $93.20 M(-5.3%) |
| Mar 1992 | - | $98.40 M(-4.7%) |
| Dec 1991 | $103.30 M(+401.5%) | $103.30 M(-3.9%) |
| Sep 1991 | - | $107.50 M(-1.6%) |
| Jun 1991 | - | $109.30 M(+430.6%) |
| Dec 1990 | $20.60 M | $20.60 M |
FAQ
- What is Regeneron Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals annual working capital year-on-year change?
- What is Regeneron Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Regeneron Pharmaceuticals?
- What is Regeneron Pharmaceuticals quarterly working capital year-on-year change?
What is Regeneron Pharmaceuticals annual working capital?
The current annual working capital of REGN is $14.72 B
What is the all time high annual working capital for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high annual working capital is $16.06 B
What is Regeneron Pharmaceuticals annual working capital year-on-year change?
Over the past year, REGN annual working capital has changed by -$1.34 B (-8.34%)
What is Regeneron Pharmaceuticals quarterly working capital?
The current quarterly working capital of REGN is $14.72 B
What is the all time high quarterly working capital for Regeneron Pharmaceuticals?
Regeneron Pharmaceuticals all-time high quarterly working capital is $16.06 B
What is Regeneron Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, REGN quarterly working capital has changed by -$1.34 B (-8.34%)